These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 24304018

  • 1. Cytokine gene modification of bladder cancer cells for the establishment of bladder cancer vaccine.
    Saito S, Tazaki H, Heston WD, Fair WR.
    Int J Urol; 1996 Jan; 3(1 Suppl):S35-9. PubMed ID: 24304018
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model.
    Horiguchi Y, Larchian WA, Kaplinsky R, Fair WR, Heston WD.
    Gene Ther; 2000 May; 7(10):844-51. PubMed ID: 10845722
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antitumor activity of interleukin-12 against murine bladder cancer.
    Eto M, Harada M, Tamada K, Tokuda N, Koikawa Y, Nakamura M, Nomoto K, Naito S.
    J Urol; 2000 May; 163(5):1549-52. PubMed ID: 10751886
    [Abstract] [Full Text] [Related]

  • 9. Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines.
    Saito S, Bannerji R, Gansbacher B, Rosenthal FM, Romanenko P, Heston WD, Fair WR, Gilboa E.
    Cancer Res; 1994 Jul 01; 54(13):3516-20. PubMed ID: 8012975
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-12 immunotherapy of murine transitional cell carcinoma of the bladder: dose dependent tumor eradication and generation of protective immunity.
    O'Donnell MA, Luo Y, Hunter SE, Chen X, Hayes LL, Clinton SK.
    J Urol; 2004 Mar 01; 171(3):1330-5. PubMed ID: 14767343
    [Abstract] [Full Text] [Related]

  • 11. Novel immunotherapy for metastatic bladder cancer using vaccine of human interleukin-2 surface-modified MB 49 cells.
    Zhang X, Shi X, Li J, Hu Z, Guo F, Huang X, Zhang Z, Sun P, Jing Y, Gao J, Tan W.
    Urology; 2011 Sep 01; 78(3):722.e1-722.e6. PubMed ID: 21741685
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
    Yamada H, Matsumoto S, Matsumoto T, Yamada T, Yamashita U.
    J Urol; 2000 Aug 01; 164(2):526-31. PubMed ID: 10893638
    [Abstract] [Full Text] [Related]

  • 14. Intravesical interleukin-15 gene therapy in an orthotopic bladder cancer model.
    Matsumoto K, Kikuchi E, Horinaga M, Takeda T, Miyajima A, Nakagawa K, Oya M.
    Hum Gene Ther; 2011 Nov 01; 22(11):1423-32. PubMed ID: 21554107
    [Abstract] [Full Text] [Related]

  • 15. Antitumor immunity against bladder cancer induced by ex vivo expression of CD40 ligand gene using retrovirus vector.
    Kimura T, Ohashi T, Kikuchi T, Kiyota H, Eto Y, Ohishi Y.
    Cancer Gene Ther; 2003 Nov 01; 10(11):833-9. PubMed ID: 14605669
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
    Yu DS, Lee CF, Hsieh DS, Chang SY.
    Urology; 2004 Mar 01; 63(3):596-601. PubMed ID: 15028475
    [Abstract] [Full Text] [Related]

  • 18. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 01; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 19. A novel therapeutic vaccine of mouse GM-CSF surface modified MB49 cells against metastatic bladder cancer.
    Zhang X, Shi X, Li J, Hu Z, Zhou D, Gao J, Tan W.
    J Urol; 2012 Mar 01; 187(3):1071-9. PubMed ID: 22266013
    [Abstract] [Full Text] [Related]

  • 20. Treatment of bladder carcinomas using recombinant BCG DNA vaccines and electroporative gene immunotherapy.
    Lee CF, Chang SY, Hsieh DS, Yu DS.
    Cancer Gene Ther; 2004 Mar 01; 11(3):194-207. PubMed ID: 14973549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.